Burning Rock Biotech Ltd (BNR)
3.70
+0.20
(+5.71%)
USD |
NASDAQ |
Nov 14, 16:00
3.76
+0.06
(+1.62%)
After-Hours: 20:00
Burning Rock Biotech Enterprise Value: -37.36M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -37.36M |
| November 12, 2024 | -37.06M |
| November 11, 2024 | -34.90M |
| November 08, 2024 | -37.98M |
| November 07, 2024 | -36.34M |
| November 06, 2024 | -38.80M |
| November 05, 2024 | -42.39M |
| November 04, 2024 | -45.47M |
| November 01, 2024 | -44.54M |
| October 31, 2024 | -44.44M |
| October 30, 2024 | -44.24M |
| October 29, 2024 | -44.65M |
| October 28, 2024 | -44.03M |
| October 25, 2024 | -44.34M |
| October 24, 2024 | -44.03M |
| October 23, 2024 | -44.34M |
| October 22, 2024 | -43.47M |
| October 21, 2024 | -42.08M |
| October 18, 2024 | -42.03M |
| October 17, 2024 | -43.42M |
| October 16, 2024 | -43.21M |
| October 15, 2024 | -43.62M |
| October 14, 2024 | -41.16M |
| October 11, 2024 | -40.03M |
| October 10, 2024 | -39.57M |
| Date | Value |
|---|---|
| October 09, 2024 | -38.39M |
| October 08, 2024 | -36.70M |
| October 07, 2024 | -34.80M |
| October 04, 2024 | -35.21M |
| October 03, 2024 | -36.54M |
| October 02, 2024 | -36.54M |
| October 01, 2024 | -39.21M |
| September 30, 2024 | -39.77M |
| September 27, 2024 | -39.93M |
| September 26, 2024 | -38.49M |
| September 25, 2024 | -44.03M |
| September 24, 2024 | -45.26M |
| September 23, 2024 | -36.54M |
| September 20, 2024 | -40.13M |
| September 19, 2024 | -37.60M |
| September 18, 2024 | -37.53M |
| September 17, 2024 | -38.90M |
| September 16, 2024 | -36.65M |
| September 13, 2024 | -36.65M |
| September 12, 2024 | -37.57M |
| September 11, 2024 | -24.34M |
| September 10, 2024 | -24.34M |
| September 09, 2024 | -24.03M |
| September 06, 2024 | -25.67M |
| September 05, 2024 | -25.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-45.47M
Minimum
Nov 04 2024
3.799B
Maximum
Feb 22 2021
874.18M
Average
177.32M
Median
Apr 18 2023
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -6.942B |
| CASI Pharmaceuticals Inc | 91.55M |
| Zai Lab Ltd | 2.423B |
| Adagene Inc | 29.78M |
| LakeShore Biopharma Co Ltd | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.02M |
| Revenue (Quarterly) | 18.84M |
| Total Expenses (Quarterly) | 34.31M |
| EPS Diluted (Quarterly) | -1.460 |
| Gross Profit Margin (Quarterly) | 70.42% |
| Profit Margin (Quarterly) | -79.71% |
| Earnings Yield | -204.3% |
| Normalized Earnings Yield | -204.32 |